Research ArticleClinical Investigation
[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
Swayamjeet Satapathy, Ranjit K. Sahoo and Chandrasekhar Bal
Journal of Nuclear Medicine August 2023, 64 (8) 1266-1271; DOI: https://doi.org/10.2967/jnumed.123.265414
Swayamjeet Satapathy
1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and
Ranjit K. Sahoo
2Department of Medical Oncology, B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
Chandrasekhar Bal
1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue 8
August 1, 2023
[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
Swayamjeet Satapathy, Ranjit K. Sahoo, Chandrasekhar Bal
Journal of Nuclear Medicine Aug 2023, 64 (8) 1266-1271; DOI: 10.2967/jnumed.123.265414
[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
Swayamjeet Satapathy, Ranjit K. Sahoo, Chandrasekhar Bal
Journal of Nuclear Medicine Aug 2023, 64 (8) 1266-1271; DOI: 10.2967/jnumed.123.265414